View Cart  

Omthera Pharmaceuticals Presents Data From Analysis of EVOLVE Trial Showing Epanova Lowers ApoC-III

A A
Omthera Pharmaceuticals presented data from the company’s Phase III EVOLVE (EpanoVa fOr Lowering Very High triglyceridEs) trial at the Scientific Sessions of the American Heart Association.
The Sacramento Bee